Status: current, Defined. Date: 31-Oct 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4750371000168117 | elasomeran + imelasomeran (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4750381000168119 | elasomeran + imelasomeran | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4750511000168115 | mRNA-1273.214 encoding SARS-CoV-2 spike protein | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4750521000168110 | COVID-19 mRNA-1273.214 bivalent vaccine | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| elasomeran + imelasomeran | Is a | elasomeran | true | Inferred relationship | Some | ||
| elasomeran + imelasomeran | has intended active ingredient | elasomeran | true | Inferred relationship | Some | 896215337 | |
| elasomeran + imelasomeran | has intended active ingredient | imelasomeran | true | Inferred relationship | Some | 73871164 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 5 mL vial | Is a | True | elasomeran + imelasomeran | Inferred relationship | Some | |
| elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | Is a | True | elasomeran + imelasomeran | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR